Clinical Trial

Hematological Profiles of Preterm Infants and the Impact of Antenatal Steroids

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to investigate the impact of antenatal corticosteroids (ANS) administration on haematological parameters in premature infants born to women exposed to ANS. The primary objective is to assess whether ANS administration in pregnant women during pregnancy alters haematological parameters in preterm neonates; The secondary objectives are: (1) to evaluate changes in haematological parameters in preterm infants in relation to the time interval between ANS administration and delivery, and (2) to assess alterations in haematological parameters according to different maternal ANS dosage regimens. A total of 524 mother-infant pairs were included in the study. Participants were allocated into six groups based on the time interval between antenatal corticosteroid administration and delivery.
Trial Details
NCT Number NCT07358845
Lead Sponsor Princess Anna Mazowiecka Hospital, Warsaw, Poland
Conditions Haematology
Enrollment 1,048 participants
Start Date 2011-01-02
Primary Completion 2013-12-30 (estimated)
Study Completion 2013-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-22